Jefferies Maintains a 'Buy' on Celgene (CELG); Positive Feedback in Myeloma Survey
Tweet Send to a FriendGet Alerts CELG Hot Sheet
Price: $123.44 -0.05%
Rating Summary:
19 Buy, 9 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 28 | New: 14
Rating Summary:
19 Buy, 9 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 28 | New: 14
Trade CELG Now!
Jefferies maintains a 'Buy' on Celgene (NASDAQ: CELG) price target of $81.00 (from $80.00).
Analyst, Thomas Wei, said, "We conducted a survey of 54 US multiple myeloma (MM) physicians. Feedback on Revlimid maintenance was incrementally positive for penetration and therapy duration, and we are raising our estimates and price target to $81 to account for longer duration of Revlimid therapy and higher pomalidomide penetration."
FY12 raised from $4.72 to $4.78 and FY13 from $4.73 to $4.79.
For an analyst ratings summary and ratings history on Celgene click here. For more ratings news on Celgene click here.
Shares of Celgene closed at $70.81 yesterday, with a 52 week range of $55.10-$80.42.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Thomas Wei, said, "We conducted a survey of 54 US multiple myeloma (MM) physicians. Feedback on Revlimid maintenance was incrementally positive for penetration and therapy duration, and we are raising our estimates and price target to $81 to account for longer duration of Revlimid therapy and higher pomalidomide penetration."
FY12 raised from $4.72 to $4.78 and FY13 from $4.73 to $4.79.
For an analyst ratings summary and ratings history on Celgene click here. For more ratings news on Celgene click here.
Shares of Celgene closed at $70.81 yesterday, with a 52 week range of $55.10-$80.42.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- KeyBank Upgrades MDC Holdings (MDC); Cuts PulteGroup (PHM) & Ryland Group (RYL)
- Dougherty & Co Raises PT on SodaStream (SODA) to $80
- The ExOne Company (XONE) Metal Opportunity to Keep Stock Going - FBR
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
Jefferies & Co
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
